MXPA06000278A - Composicion de vacuna para vacunar perros contra enfermedad respiratoria infecciosa canina. - Google Patents
Composicion de vacuna para vacunar perros contra enfermedad respiratoria infecciosa canina.Info
- Publication number
- MXPA06000278A MXPA06000278A MXPA06000278A MXPA06000278A MXPA06000278A MX PA06000278 A MXPA06000278 A MX PA06000278A MX PA06000278 A MXPA06000278 A MX PA06000278A MX PA06000278 A MXPA06000278 A MX PA06000278A MX PA06000278 A MXPA06000278 A MX PA06000278A
- Authority
- MX
- Mexico
- Prior art keywords
- vaccine composition
- cird
- respiratory disease
- against canine
- infectious respiratory
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/118—Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/295—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Chlamydiales (o)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/30—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/315—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Streptococcus (G), e.g. Enterococci
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/12—Pulmonary diseases
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Una composicion de vacuna para vacunacion de perros que comprende cualesquiera uno o mas de (a) un agente capaz de generar una respuesta inmune contra Streptococcus equi sub especies zooepidemicus en un perro, (b) un agente capaz de generar una respuesta inmune contra Mycoplasma cynos en un perro, y (c) un agente capaz de generar una respuesta inmune contra una Chlamydophila en un perro.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0315323.6A GB0315323D0 (en) | 2003-07-01 | 2003-07-01 | Vaccine composition |
PCT/GB2004/002865 WO2005002618A1 (en) | 2003-07-01 | 2004-07-01 | Vaccine composition for vaccinating dogs against canine infectious respiratory disease (cird) |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA06000278A true MXPA06000278A (es) | 2006-04-07 |
Family
ID=27676393
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA06000278A MXPA06000278A (es) | 2003-07-01 | 2004-07-01 | Composicion de vacuna para vacunar perros contra enfermedad respiratoria infecciosa canina. |
Country Status (20)
Country | Link |
---|---|
US (3) | US8329194B2 (es) |
EP (2) | EP1638599B1 (es) |
JP (1) | JP5698890B2 (es) |
KR (1) | KR20060106809A (es) |
CN (1) | CN1845754A (es) |
AT (1) | ATE442857T1 (es) |
AU (1) | AU2004253344B2 (es) |
BR (1) | BRPI0412194A (es) |
CA (1) | CA2530797C (es) |
DE (1) | DE602004023196D1 (es) |
DK (1) | DK2050463T3 (es) |
ES (2) | ES2432175T3 (es) |
GB (1) | GB0315323D0 (es) |
MX (1) | MXPA06000278A (es) |
NO (1) | NO20056207L (es) |
NZ (1) | NZ544453A (es) |
PT (1) | PT2050463E (es) |
RU (1) | RU2006102863A (es) |
WO (1) | WO2005002618A1 (es) |
ZA (1) | ZA200600918B (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11865172B2 (en) | 2005-04-21 | 2024-01-09 | University Of Florida Research Foundation, Inc. | Materials and methods for respiratory disease control in canines |
US7682619B2 (en) | 2006-04-06 | 2010-03-23 | Cornell Research Foundation, Inc. | Canine influenza virus |
CN100388952C (zh) * | 2006-04-25 | 2008-05-21 | 范红结 | 一种链球菌重组亚单位疫苗及其制备方法 |
KR101192127B1 (ko) * | 2006-11-03 | 2012-10-17 | 쉐링-프라우 리미티드 | 개 라임병 백신 |
EP2544717B1 (en) * | 2010-03-10 | 2018-08-15 | Intervet International B.V. | Method for protecting against disease caused by secondary pathogens |
MX347177B (es) * | 2011-02-04 | 2017-04-17 | Zoetis Services Llc | Composiciones inmunogenas de bordetella bronchiseptica. |
BR112013019850B1 (pt) * | 2011-02-04 | 2023-02-28 | Zoetis Services Llc | Composições de vacina e seu uso no tratamento ou prevenção de doenças respiratórias infecciosas caninas |
WO2013181086A1 (en) * | 2012-05-31 | 2013-12-05 | Zoetis Llc | Vaccination with canine respiratory coronavirus for protection against b. bronchiseptica infections |
CN111499702B (zh) * | 2020-05-07 | 2021-04-06 | 山东畜牧兽医职业学院 | 一种马链球菌兽疫亚种的检测试剂盒及检测方法 |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE8205892D0 (sv) | 1982-10-18 | 1982-10-18 | Bror Morein | Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin |
US4567042A (en) * | 1983-06-15 | 1986-01-28 | American Home Products Corporation | Inactivated canine coronavirus vaccine |
US4567043A (en) * | 1983-06-15 | 1986-01-28 | American Home Products Corporation (Del.) | Canine corona virus vaccine |
GB8426468D0 (en) * | 1984-10-19 | 1984-11-28 | Technology Licence Co Ltd | Monoclonal antibodies |
SE8405493D0 (sv) | 1984-11-01 | 1984-11-01 | Bror Morein | Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel |
GB8517895D0 (en) * | 1985-07-16 | 1985-08-21 | Technology Licence Co Ltd | Monoclonal antibodies |
ATE71303T1 (de) | 1986-01-14 | 1992-01-15 | Nederlanden Staat | Verfahren zur herstellung immunologischer komplexe und diese enthaltende pharmazeutische zusammensetzung. |
US4806352A (en) | 1986-04-15 | 1989-02-21 | Ribi Immunochem Research Inc. | Immunological lipid emulsion adjuvant |
US4944942A (en) * | 1987-08-27 | 1990-07-31 | Mobay Corporation | Intranasal vaccination of horses with inactivated microorganisms or antigenic material |
US4944972A (en) * | 1987-12-31 | 1990-07-31 | American National Can Company | Coextrusion apparatus, methods, and related films and packages |
US5672350A (en) | 1989-08-22 | 1997-09-30 | Veterinary Infectious Disease Organization | Recombinant bovine coronavirus E2 and E3 polypeptides and vaccines |
US5178860A (en) * | 1989-09-01 | 1993-01-12 | Coopers Animal Health Limited | Adjuvant complexes and vaccine made therefrom |
GB8919819D0 (en) * | 1989-09-01 | 1989-10-18 | Coopers Animal Health | Complexes having adjuvant activity |
US5583014A (en) * | 1990-07-03 | 1996-12-10 | Bayer Corporation | Preparation and use of enzyme-detergent extracted Streptococcus zoopidemicus vaccine |
NZ240558A (en) | 1990-11-14 | 1994-11-25 | Smithkline Beecham Corp | Recombinant feline coronavirus s proteins useful in diagnosis and vaccination against feline peritonitis virus disease |
US6372224B1 (en) | 1990-11-14 | 2002-04-16 | Pfizer Inc. | Canine coronavirus S gene and uses therefor |
US6057436A (en) | 1990-11-14 | 2000-05-02 | Pfizer Inc. | Canine coronavirus S gene and uses therefor |
ATE256746T1 (de) | 1991-04-25 | 2004-01-15 | Akzo Nobel Nv | Subeinheits-impfstoff gegen hundecoronavirus |
DE4134297A1 (de) * | 1991-10-17 | 1993-04-22 | Behringwerke Ag | Monoclonale antikoerper gegen mycoplasma pneumoniae, diese produzierende hybridome, verfahren zu deren herstellung sowie deren verwendung |
JP3245169B2 (ja) | 1992-05-08 | 2002-01-07 | ファイザー・インコーポレイテッド | イヌ・コロナウイルスs遺伝子およびその使用 |
US5750112A (en) | 1993-02-26 | 1998-05-12 | Solvay Animal Health, Inc. | Canine coronavirus vaccine from feline enteric coronavirus |
DK0744937T3 (da) * | 1994-02-18 | 2002-10-28 | Solidose L L C | Vaccination af dyr med tørrede, pelleterede biologiske materialer |
WO1996041874A1 (en) | 1995-06-12 | 1996-12-27 | Kansas State University Research Foundation | Multivalent bovine coronavirus vaccine and method of treating bovine coronavirus infection |
US5753235A (en) * | 1996-02-15 | 1998-05-19 | Heska Corporation | Recombinant canine herpesviruses |
WO1998016643A1 (en) | 1996-10-11 | 1998-04-23 | Human Genome Sciences, Inc. | Brain-associated inhibitor of tissue-type plasminogen activator |
US6080725A (en) * | 1997-05-20 | 2000-06-27 | Galenica Pharmaceuticals, Inc. | Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof |
US6682745B1 (en) * | 1998-07-28 | 2004-01-27 | Christiaan Antonius Arnoldus Jacobs | Use of bacterium for manufacture of a vaccine |
AU1408499A (en) | 1997-11-14 | 1999-06-07 | Thomas P. Brown | Compositions and methods to prevent turkey enteritis |
US6248329B1 (en) * | 1998-06-01 | 2001-06-19 | Ramaswamy Chandrashekar | Parasitic helminth cuticlin nucleic acid molecules and uses thereof |
ES2214217T3 (es) * | 1999-01-26 | 2004-09-16 | Akzo Nobel N.V. | Utilizacion de bacterias vivas atenuadas para la preparacion de una vacuna de administracion por la submucosa. |
US20010048927A1 (en) * | 2000-02-01 | 2001-12-06 | Richard Stephens | Porin B (PorB) as a therapeutic target for prevention and treatment of infection by chlamydia |
US6548069B2 (en) * | 2001-02-03 | 2003-04-15 | Hmv Associates, Inc. | Multivalent Mycoplasma bacterin |
WO2003018051A1 (en) * | 2001-08-27 | 2003-03-06 | Vic Jira | Anti-fungal composition |
GB0217434D0 (en) * | 2002-07-27 | 2002-09-04 | Royal Vetinary College | Biological material |
WO2004032957A1 (en) | 2002-10-11 | 2004-04-22 | Bengt Guss | Immunization of non-human mammals against streptococcus equi |
US7793433B2 (en) * | 2006-07-14 | 2010-09-14 | Footbalance System Oy | Individually formed footwear and a related method |
-
2003
- 2003-07-01 GB GBGB0315323.6A patent/GB0315323D0/en not_active Ceased
-
2004
- 2004-07-01 PT PT80759145T patent/PT2050463E/pt unknown
- 2004-07-01 EP EP04743211A patent/EP1638599B1/en active Active
- 2004-07-01 US US10/563,199 patent/US8329194B2/en active Active
- 2004-07-01 DE DE602004023196T patent/DE602004023196D1/de active Active
- 2004-07-01 BR BRPI0412194-5A patent/BRPI0412194A/pt not_active Application Discontinuation
- 2004-07-01 RU RU2006102863/15A patent/RU2006102863A/ru not_active Application Discontinuation
- 2004-07-01 JP JP2006518335A patent/JP5698890B2/ja not_active Expired - Fee Related
- 2004-07-01 MX MXPA06000278A patent/MXPA06000278A/es unknown
- 2004-07-01 CA CA2530797A patent/CA2530797C/en not_active Expired - Fee Related
- 2004-07-01 AU AU2004253344A patent/AU2004253344B2/en not_active Ceased
- 2004-07-01 EP EP08075914.5A patent/EP2050463B1/en active Active
- 2004-07-01 CN CNA2004800250016A patent/CN1845754A/zh active Pending
- 2004-07-01 ES ES08075914T patent/ES2432175T3/es active Active
- 2004-07-01 WO PCT/GB2004/002865 patent/WO2005002618A1/en active Application Filing
- 2004-07-01 AT AT04743211T patent/ATE442857T1/de not_active IP Right Cessation
- 2004-07-01 NZ NZ544453A patent/NZ544453A/xx not_active IP Right Cessation
- 2004-07-01 DK DK08075914.5T patent/DK2050463T3/da active
- 2004-07-01 KR KR1020067000080A patent/KR20060106809A/ko not_active Application Discontinuation
- 2004-07-01 ES ES04743211T patent/ES2356396T3/es active Active
-
2005
- 2005-12-27 NO NO20056207A patent/NO20056207L/no not_active Application Discontinuation
-
2006
- 2006-01-31 ZA ZA200600918A patent/ZA200600918B/en unknown
-
2007
- 2007-09-04 US US11/849,931 patent/US20080220018A1/en not_active Abandoned
-
2010
- 2010-06-15 US US12/816,214 patent/US20110059128A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1638599A1 (en) | 2006-03-29 |
ZA200600918B (en) | 2007-07-25 |
KR20060106809A (ko) | 2006-10-12 |
BRPI0412194A (pt) | 2006-08-22 |
AU2004253344B2 (en) | 2010-04-29 |
CA2530797C (en) | 2014-08-26 |
JP2007526884A (ja) | 2007-09-20 |
US20070098739A1 (en) | 2007-05-03 |
GB0315323D0 (en) | 2003-08-06 |
WO2005002618A1 (en) | 2005-01-13 |
DK2050463T3 (da) | 2013-09-02 |
ES2432175T3 (es) | 2013-12-02 |
US8329194B2 (en) | 2012-12-11 |
NO20056207L (no) | 2006-01-31 |
AU2004253344A1 (en) | 2005-01-13 |
EP2050463A2 (en) | 2009-04-22 |
EP1638599B1 (en) | 2009-09-16 |
JP5698890B2 (ja) | 2015-04-08 |
EP2050463A3 (en) | 2010-01-20 |
US20080220018A1 (en) | 2008-09-11 |
EP2050463B1 (en) | 2013-08-21 |
CN1845754A (zh) | 2006-10-11 |
ATE442857T1 (de) | 2009-10-15 |
PT2050463E (pt) | 2013-10-29 |
RU2006102863A (ru) | 2006-09-10 |
US20110059128A1 (en) | 2011-03-10 |
ES2356396T3 (es) | 2011-04-07 |
NZ544453A (en) | 2009-04-30 |
DE602004023196D1 (de) | 2009-10-29 |
CA2530797A1 (en) | 2005-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA27047A1 (fr) | Vaccination unidose avec mycoplasma hyopneumoniae. | |
SG163598A1 (en) | Lawsonia vaccine and methods of use thereof | |
MXPA06000278A (es) | Composicion de vacuna para vacunar perros contra enfermedad respiratoria infecciosa canina. | |
DK1675573T4 (da) | Steril, injicerbr aripiprazol-formulering med kontrolleret frigivelse samt fremgangsmåde | |
NO20015073D0 (no) | Vaksiner | |
ZA200309747B (en) | Mycoplasma bovis vaccine and methods of reducing pneumonia in animals. | |
ATE513560T1 (de) | Kombinationsimpfstoff gegen bakterielle meningitis, der über die schleimhaut appliziert wird | |
DE60012042D1 (de) | Entepneumovirus und entsprechendes impfstoff | |
HUP0301634A2 (hu) | Hőmérséklet-érzékeny, élő vakcina Mycoplasma hyopneumoniaera | |
ATE526034T1 (de) | Verbesserte inaktivierte fcv-vakzinen | |
ATE310008T1 (de) | Immunologische adjuvans verbindungen | |
HUP0401077A2 (hu) | Mycoplasma bovis fertőzési modell, valamint eljárások M. bovis bejuttatására és tüdőgyulladásos tüdőléziók indukálására | |
MY138203A (en) | Novel bacterial poultry disease | |
DE602004031092D1 (de) | Virulentes systemisches felines calicivirus | |
WO2004073604A3 (en) | Dna vaccines that express an adp-ribosyltransferase toxin devoid of adp-ribosyltransferase activity | |
AU2003294192A1 (en) | Inclusion bodies as antigens for the oral vaccination of animals against csfv | |
WO2004058816A3 (en) | Inclusion bodies for the oral vaccination of animals | |
AR035202A1 (es) | Vacuna viva termo-sensible contra mycoplasma hyopneumoniae | |
Perino | Advances in pulmonary immunology | |
SE0301380L (sv) | Ventilerat golv, däri ingående golvskiva samt förfarande för tillverkning av en sådan | |
WO2007062795A3 (de) | Bakterieller impfstoff gegen bakterielle infektionserreger für die anwendung bei tieren | |
FI20031065A0 (fi) | Hyönteissuoja-aine, menetelmä sen valmistamiseksi ja sen käyttö | |
TW200612982A (en) | Vaccine composed of Mycoplasma hyopneumoniae and bacterial antigen and method for manufacturing thereof | |
AR042035A1 (es) | Uso de rmlt como antigeno marcador para vacunas y como un aditivo sinergico con amphigen | |
Otake et al. | Biosecurity in PRRSV control/eradication: research update and field applications. |